Pfizer receives approval to store vaccine at higher temperatures

Yesterday, the U.S. Food and Drug administration (FDA) provided approval for the Pfizer vaccine to be stored at a standard freezer temperature for up to two weeks instead of the deep-frozen temperature range that was previously required which will make the delivery of the vaccine easier.
 
This is great news for temperature-controlled packaging companies such as Pelican BioThermal that play a vital role in ensuring the vaccines remain within the correct temperature ranges during transport allowing for greater distribution worldwide of the COVID-19 vaccine to the clinics and ultimately to the patients who receive them.

Read the full article here